Cyclo-oxygenase pathway metabolites released in the microenvironment by activated platelets and endothelial cells are potential local modulators of the immune response. In the present study, we have investigated the modulatory role of PGE2, Iloprost (prostacyclin analogue) U-46619 (thromboxane analogue) on the release of IL-2, IFN-gamma, TNF-alpha and IL-6 by T lymphocytes. Our results show that PGE2, and prostacyclin differ in the regulation of cytokine production. PGE2, inhibited the release of IL-2 and IFN-gamma, while Iloprost did not affect their production. The addition of PGE2, or Iloprost greatly decreased the amount of TNF-alpha measured in the supernatants, although the rates of inhibition differed according-to the kind of stimulation. Unlike that of PGE2, inhibition by Iloprost was stronger in alloactivated cultures than in PHA-stimulated ones. In vitro IL-6 production was stimulated by PGE2, in alloactivated cultures and by Iloprost, whatever the stimulus. These results are probably due to other cellular subsets contaminating the T-lymphocyte preparations. After complete removal of monocytes from cell cultures, there were inhibitory effects of Iloprost and PGE2, on IL-6 released in the supernatants. We did not observe any significant effect of thromboxane analogue on the production of either cytokine.
|Number of pages||8|
|Journal||Prostaglandins, Leukotrienes and Essential Fatty Acids|
|Publication status||Published - Mar 1997|
ASJC Scopus subject areas
- Clinical Biochemistry
- Endocrinology, Diabetes and Metabolism